Clorox (NYSE:CLX – Get Free Report) was downgraded by investment analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a report issued on Tuesday,Zacks.com reports.
A number of other research analysts also recently issued reports on CLX. Wall Street Zen raised Clorox from a “sell” rating to a “hold” rating in a report on Saturday, February 7th. Morgan Stanley lowered their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a report on Friday, May 1st. Rothschild & Co Redburn set a $117.00 price target on Clorox in a report on Friday, February 13th. Jefferies Financial Group lowered their price target on Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a report on Monday, May 4th. Finally, Evercore reaffirmed an “underperform” rating and set a $110.00 price target on shares of Clorox in a report on Friday, May 1st. One analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat, Clorox currently has an average rating of “Reduce” and a consensus price target of $103.73.
Get Our Latest Stock Report on CLX
Clorox Trading Up 3.4%
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company’s quarterly revenue was up .1% on a year-over-year basis. During the same period in the prior year, the company posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Sell-side analysts expect that Clorox will post 5.63 earnings per share for the current year.
Insider Activity at Clorox
In related news, Director Pierre R. Breber acquired 5,000 shares of the firm’s stock in a transaction dated Tuesday, May 5th. The shares were purchased at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. This represents a 38.46% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.63% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in the stock. Dickmeyer Boyce Financial Management Inc. bought a new position in shares of Clorox in the first quarter worth about $456,000. Sei Investments Co. grew its position in shares of Clorox by 21.1% during the first quarter. Sei Investments Co. now owns 59,425 shares of the company’s stock worth $6,157,000 after purchasing an additional 10,373 shares in the last quarter. Lido Advisors LLC grew its position in shares of Clorox by 31.4% during the first quarter. Lido Advisors LLC now owns 12,975 shares of the company’s stock worth $1,345,000 after purchasing an additional 3,104 shares in the last quarter. Cetera Investment Advisers grew its position in shares of Clorox by 44.5% during the first quarter. Cetera Investment Advisers now owns 105,704 shares of the company’s stock worth $10,954,000 after purchasing an additional 32,539 shares in the last quarter. Finally, PNC Financial Services Group Inc. grew its position in shares of Clorox by 3.0% during the first quarter. PNC Financial Services Group Inc. now owns 83,889 shares of the company’s stock worth $8,693,000 after purchasing an additional 2,439 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.
Clorox Company Profile
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
See Also
- Five stocks we like better than Clorox
- Oklo Stock Could Be Ready for Another Massive Run
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
